Mamluk Roni 4
4 · Ayala Pharmaceuticals, Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Mamluk Roni
DirectorCEO
Transactions
- Award
Stock Option
2022-01-03+127,800→ 127,800 totalExercise: $9.11Exp: 2032-01-02→ Common Stock (127,800 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in sixteen substantially equal quarterly installments following the grant date, such that the option shall be fully vested on January 3, 2026.